Incorporated in 2005, GreenSignal Bio Pharma is Chennai based pharmaceutical company engaged in the development, manufacture and sale of the BCG vaccine. source chittorgarh.com, India's No. 1 IPO Investment Portal. GreenSignal is an Indian vaccine manufacturing company with global operations. The products company manufacture includes a BCG vaccine and BCG-ONCO, an immunotherapy drug. The immunotherapy drug is used in the treatment of urinary bladder cancer.
Both vaccines produced by GreenSignal are generic drugs and company do not require any patents for the same.
GreenSignal has a long term contract with UNICEF to supply the BCG vaccine to UNICEF. GreenSignal is among 4 companies worldwide who have been WHO-prequalified to supply the BCG vaccine to UNICEF. Other customers include Indonesia, Nepal and Ministry of Health, India.
GreenSignal Pharma business is organized into domestic and international operations. For FY 2016, GreenSignal's domestic and international operations accounted for 53.79% and 46.20%, respectively, of its net revenues from operations. Visit chittorgarh.com for more detail.
GreenSignal Bio have a manufacturing facility located at Pappankuppam Village, Gummidipoondi, Tiruvallur District, Tamil Nadu.
The promoters of the company are:
1. Mr P. Sundaraparipooranan
2. Dr. P. Murali
|Particulars||For the year/period ended (in Rs. Lacs)|
|As at 30-Jun-16||31-Mar-16||31-Mar-15||31-Mar-14||31-Mar-13||31-Mar-12|
|Profit After Tax (PAT)||293.09||530.95||(21.33)||(129.71)||(50.01)||(48.11)|
The objects of the Offer are to:
1. Achieve the benefits of listing the Equity Shares on the BSE and the NSE;
2. To carry out the sale of up to 14,579,560 Equity Shares by the Selling Shareholders;
3. Enhance visibility and brand image among existing and potential customers; and
4. Provide liquidity to the existing shareholders.
|Issue Open||Nov 9, 2016 - Nov 22, 2016|
|Issue Type||Book Built Issue IPO|
|Offer for Sale||14,579,560 Eq Shares of Rs 10 |
(aggregating up to Rs [.] Cr)
|Face Value||Rs 10 Per Equity Share|
|Issue Price||Rs 68 - Rs 76 Per Equity Share|
|Market Lot||175 Shares|
|Min Order Quantity||175 Shares|
|Listing At||BSE, NSE|
Book Running Lead Managers to the GreenSignal Bio Pharma Limited, has informed the Exchange that according to 26 (2) of SEBI (ICDR) Regulations, if 75% of the net offer to public cannot be allotted to QIBs, the entire application money shall be refunded forthwith. Hence, the IPO of GreenSignal Bio Pharama Limited may be treated as withdrawn.
Book Running Lead Managers to the GreenSignal Bio Pharma Limited, has informed the Exchange that the issue closure date has been further extended upto 22 Nov,2016. Post issue modification date has been revised to 23 Nov,2016. Price band has been revised to Rs 68/- to Rs 76/-
Book Running Lead Managers to the GreenSignal Bio Pharma Limited, has informed the Exchange that the issue closure date has been extended upto 17 Nov,2016. Post issue modification date has been revised to 18 Nov,2016.
No. of Times Issue Subscribed (BSE + NSE)
As on Date & Time
Nov 22, 2016 17:00
Vote Here ...
You could reduce the brokerage cost significantly by moving to another stock broker. Our expert team compared top share brokers in India to help traders. STOP paying Demat AMC, Brokerage in %, PCM Fee and High Stamp Duty today.
We can help you choosing the right broker. Contact us today...